Vaxil Bio Ltd(VXL-X)
TSX Venture

Today's Change
Delayed Last Update

Vaxil Bio Ltd

559 Briar Hill Avenue
Toronto ON M5N 1N1 CAN
P: 647-558-5564
https://www.vaxil-bio.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.

    Key Executives

    NameTitle
    Gadi LevinCEO/Chairman of the Board/Director
    Alan RootenbergCFO

    More from The Globe

    top links
    Barlow’s Research Roundup: These stocks are the big winners from Canada’s new nuclear energy plan
    Future headquarters of Ontario Power Generation, Oshawa, March 2025.
    Gildan stock is down, and looking good
    Signage is seen at Gildan Activewear Inc.'s annual meeting in Montreal, Tuesday, May 28, 2024. THE CANADIAN PRESS/Christinne Muschi
    the mover
    Why this money manager is buying Agnico Eagle, Nutrien and trimming Alphabet
    Illustration of Martin Pelletier for The Mover, June 19, 2026. Illustration by Joel Kimmel
    number cruncher
    Top U.S. stocks ranked by Trading Central’s quantitative model
    For Number Cruncher column in Globe Investor/ROB only.
    Wednesday’s analyst upgrades and downgrades
    A Dynamite clothing retail store is shown in Montreal, Friday, Nov. 15, 2024.
    number cruncher
    Seven Canadian small-cap stocks with cheap valuations
    For Number Cruncher column in Globe Investor/ROB only.
    Bullish on Freeport-McMoRan Inc.
    Monica Rizk
    Gildan shares sink 19 per cent on short seller report alleging inflated sales
    Gildan Activewear Inc. CEO Glenn Chamandy arrives to speak to the media following the company's annual meeting in Montreal on May 28, 2024.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.